Established by the Director, NCI, September 29, 1995. Currently authorized under 42 U.S. Code 284 (c)(3), Section 405(c)(3) of the Public Health Service Act, as amended. The Panel is governed by the provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2).

STRUCTURE

Members and Chairs will be selected on an "as needed" basis in response to specific applications, proposals or proposed solicitations to be reviewed. Approximately 660 reviewers will serve each year. Members will be selected from outstanding authorities in the various fields of biomedical research. Members of the NIH Reviewers Reserve or chartered Department of Health and Human Services advisory committees may serve on the Panel if their expertise is required.

FUNCTION

Advises the Director, National Cancer Institute (NCI), and the Director, Division of Extramural Activities, regarding research grant and cooperative agreement applications, contract proposals and concept review relating to basic and clinical sciences, and applied research and development programs of special relevance to the National Cancer Institute.

MEETINGS

Meetings of the Panel shall be held as necessary approximately 60 times per year as determined by the Designated Federal Official (DFO) who also approves the agenda. A Government official is present at all meetings.